Back to Journals » Neuropsychiatric Disease and Treatment » Volume 1 » Issue 1

SJR OA
CiteScore
Impact Factor

Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


      

Archive: Volume 1, 2005


Letter: NEURON – a network of European funding organizations ||FREE PAPER||

Marlies Dorlöchter and Hella Lichtenberg

Neuropsychiatric Disease and Treatment 2005, 1:87-88

Published Date: 15 April 2005

MRI parameters of Alzheimer’s disease in an Arab population of Wadi Ara, Israel

Abdalla Bowirrat, Irith I Reider-Groswasser, Marlene Oscar-Berman, Orna Aizenstein, Gad Levy, Amos D Korczyn

Neuropsychiatric Disease and Treatment 2005, 1:77-85

Published Date: 15 April 2005

Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer’s type in an elderly Arab population in Wadi Ara, Israel

Abdalla Bowirrat, Jing Cui, Kristin Waraska, Robert P Friedland, Marlene Oscar-Berman, Lindsay A Farrer, Amos Korczyn, Clinton T Baldwin

Neuropsychiatric Disease and Treatment 2005, 1:73-76

Published Date: 15 April 2005

Stress-induced increases in avoidance responding: an animal model of posttraumatic stress disorder behavior?

Francis X Brennan, Kevin D Beck, Richard J Ross, Richard J Servatius

Neuropsychiatric Disease and Treatment 2005, 1:69-72

Published Date: 15 April 2005

Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.

Francis Lavergne, Ivan Berlin, Alex Gamma, Hans Stassen, Jules Angst

Neuropsychiatric Disease and Treatment 2005, 1:59-68

Published Date: 15 April 2005

What moderator characteristics are associated with better prognosis for depression?

Madhukar H Trivedi, David W Morris, Ji-Yang Pan, Bruce D Grannemann, A John Rush

Neuropsychiatric Disease and Treatment 2005, 1:51-57

Published Date: 15 April 2005

Mild cognitive impairment in Parkinson’s disease: the challenge and the promise || FREE PAPER ||

Hubert H Fernandez, Gregory P Crucian, Michael S Okun, Catherine C Price, Dawn Bowers

Neuropsychiatric Disease and Treatment 2005, 1:37-50

Published Date: 15 April 2005

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Francis E Lotrich, Bruce G Pollock

Neuropsychiatric Disease and Treatment 2005, 1:17-35

Published Date: 15 April 2005

Affect regulation: a systems neuroscience perspective.

Mani N Pavuluri, Ellen S Herbener, John A Sweeney

Neuropsychiatric Disease and Treatment 2005, 1:9-15

Published Date: 15 April 2005

Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?

Roger M Pinder

Neuropsychiatric Disease and Treatment 2005, 1:3-7

Published Date: 15 April 2005

Editorial Foreword || FREE PAPER ||

Roger M Pinder

Neuropsychiatric Disease and Treatment 2005, 1:1-1

Published Date: 15 April 2005